We are thrilled to announce an ALIGN Special Seminar by one of our partners, Mark Grosser, CEO and Chairman of 23Strands.

23Strands is a wholly Australian owned startup focused on delivering truly personalised healthcare. The team is dedicated to utilising whole genome sequencing and Artificial Intelligence to unlock the power of the genetic code. They combine deep phenotype and other diagnostic pathology to provide a more accurate pathway to better patient outcomes. Since 2018, 23Strands has developed a proven capability to deliver genome-wide DNA sequencing data to allow a more accurate understanding of complex diseases and to facilitate improvements in patient care.

Please join us to hear Mark tell us more about 23Strands, and explore opportunities for deploying their expertise to progress the ALIGN agenda.

https://www.23strands.com/